Garrigues advises Keensight Capital on 3P Biopharmaceuticals deal

Garrigues advised Keensight Capital on the acquisition of 3P Biopharmaceuticals.

Keensight Capital – a ‘growth buyout’ investor that specialises in the IT and healthcare sectors – acquired a majority stake from Infarco.

3P Biopharmaceuticals specialises in the development and manufacture of medicines. The company has around 240 employees.

Garrigues advises Keensight Capital on 3P Biopharmaceuticals deal

Juan fernandez

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Legal Group, S.L.
Registered office: C/ Ríos Rosas 44A - 2 G,H 28003 Madrid España

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram